Andra AP fonden Has $14.19 Million Holdings in CME Group Inc. $CME

Andra AP fonden lowered its holdings in CME Group Inc. (NASDAQ:CME) by 53.2% in the 1st quarter, HoldingsChannel.com reports. The firm owned 48,030 shares of the financial services provider’s stock after selling 54,650 shares during the quarter. Andra AP fonden’s holdings in CME Group were worth $14,186,000 as of its most recent SEC filing.

A number of other large investors also recently modified their holdings of the stock. Vanguard Group Inc. lifted its position in shares of CME Group by 1.7% during the fourth quarter. Vanguard Group Inc. now owns 35,895,583 shares of the financial services provider’s stock valued at $9,802,366,000 after purchasing an additional 588,509 shares in the last quarter. State Street Corp grew its stake in CME Group by 0.4% in the 4th quarter. State Street Corp now owns 16,144,525 shares of the financial services provider’s stock valued at $4,408,747,000 after purchasing an additional 56,725 shares during the period. Norges Bank bought a new position in CME Group in the 4th quarter valued at $1,523,241,000. Bank of New York Mellon Corp increased its position in shares of CME Group by 2.8% during the 4th quarter. Bank of New York Mellon Corp now owns 4,924,475 shares of the financial services provider’s stock valued at $1,344,776,000 after purchasing an additional 134,242 shares during the last quarter. Finally, Raymond James Financial Inc. increased its position in shares of CME Group by 5.4% during the 4th quarter. Raymond James Financial Inc. now owns 4,319,763 shares of the financial services provider’s stock valued at $1,179,858,000 after purchasing an additional 222,890 shares during the last quarter. Institutional investors own 87.75% of the company’s stock.

CME Group Stock Down 3.1%

CME stock opened at $237.41 on Wednesday. The stock has a fifty day moving average of $256.83 and a 200-day moving average of $281.68. CME Group Inc. has a fifty-two week low of $218.31 and a fifty-two week high of $329.16. The company has a market capitalization of $86.03 billion, a price-to-earnings ratio of 20.26, a PEG ratio of 3.05 and a beta of 0.25. The company has a debt-to-equity ratio of 0.13, a quick ratio of 1.02 and a current ratio of 1.02.

CME Group (NASDAQ:CME) last announced its quarterly earnings data on Wednesday, April 22nd. The financial services provider reported $3.36 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $3.11 by $0.25. The business had revenue of $1.88 billion for the quarter, compared to analysts’ expectations of $1.77 billion. CME Group had a return on equity of 15.42% and a net margin of 63.19%.The firm’s quarterly revenue was up 14.5% compared to the same quarter last year. During the same period in the previous year, the business posted $2.80 EPS. As a group, equities research analysts predict that CME Group Inc. will post 12.18 earnings per share for the current year.

CME Group Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Thursday, June 25th. Investors of record on Tuesday, June 9th were paid a dividend of $1.30 per share. This represents a $5.20 dividend on an annualized basis and a dividend yield of 2.2%. The ex-dividend date was Tuesday, June 9th. CME Group’s dividend payout ratio is presently 44.37%.

Wall Street Analysts Forecast Growth

Several equities analysts recently weighed in on the stock. Morgan Stanley reduced their price target on shares of CME Group from $353.00 to $324.00 and set an “overweight” rating for the company in a research report on Friday, July 10th. Jefferies Financial Group lowered their price objective on shares of CME Group from $356.00 to $349.00 and set a “buy” rating on the stock in a research report on Thursday, April 9th. Deutsche Bank Aktiengesellschaft dropped their target price on shares of CME Group from $342.00 to $322.00 and set a “buy” rating on the stock in a research note on Thursday, April 23rd. JPMorgan Chase & Co. raised their price target on shares of CME Group from $266.00 to $271.00 and gave the stock an “underweight” rating in a research note on Thursday, April 16th. Finally, Erste Group Bank lowered shares of CME Group from a “buy” rating to a “hold” rating in a research note on Friday, June 5th. Twelve equities research analysts have rated the stock with a Buy rating, four have given a Hold rating and two have assigned a Sell rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $292.12.

Insider Activity at CME Group

In other CME Group news, CEO Terrence A. Duffy sold 35,000 shares of the business’s stock in a transaction on Friday, May 15th. The shares were sold at an average price of $298.51, for a total transaction of $10,447,850.00. Following the sale, the chief executive officer owned 55,630 shares of the company’s stock, valued at $16,606,111.30. The trade was a 38.62% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, insider Hilda Harris Piell sold 5,753 shares of the stock in a transaction on Monday, May 18th. The stock was sold at an average price of $304.63, for a total value of $1,752,536.39. Following the sale, the insider owned 27,702 shares in the company, valued at approximately $8,438,860.26. This represents a 17.20% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. 0.30% of the stock is currently owned by corporate insiders.

About CME Group

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.